How gene regulatory networks maintain FLT3-ITD mutated AML
Using shRNA screening enabled researchers to investigate the roles of individual specific factors in maintaining the network found in AML.
List view / Grid view
Using shRNA screening enabled researchers to investigate the roles of individual specific factors in maintaining the network found in AML.
Understanding the involvement of Nod1 in the development of blood stem cells could greatly improve blood disorder treatments.
A 2D neuromuscular junction model enables high-throughput screening to discover new treatments for neuromuscular diseases.
A new finding that pathological alpha-synuclein causes cells to increase protein synthesis suggests new targets for treating PD.
New software can make protein molecules that bind with high affinity and specificity to many biomarkers, including human hormones.
New understanding of the communication system between pathogens and host cells provides a way to avoid antimicrobial resistance.
In vitro and in vivo experiments highlight the advantages of a new targeted spectroscopy system for many eye diseases.
Understanding the mechanisms in lung formation could develop new therapeutic approaches for respiratory conditions.
The new findings could help preventive and therapeutic HIV vaccine design and development, and HIV immunotherapy approaches.
A new deep-learning method could enhance therapeutic devices for people with neurological or mental health conditions.
Using phosphoproteomics, the calcium channel Cav2.3 was found as a target to treat a type of genetic epilepsy, CDKL5 deficiency disorder.
LNPs deliver small interfering RNA to the brain’s microglia to combat inflammation related to Alzheimer’s disease.
By fusing antigen proteins into an anchor protein, a specific disease could be targeted without the need to purify the antigen.
Glioblastomas can resist immunotherapy as perivascular fibroblasts support the creation of an immunosuppressive tumour environment.
NETs require epidermal growth factor to grow, meaning that inhibiting EGF receptors could treat these types of tumours.